CHEMOTHERAPY IN MALIGNANT DISEASES OF THE GASTROINTESTINAL SYSTEM

Year 1968, Volume: 21 Issue: 4, 1247 - 1265, 31.12.1968

Atilla Erhan

https://izlik.org/JA34ZF94AK

Abstract

The therapeutic agents used for the chemotherapy of the cancer of gastrointestinal system are reviewed and recent medical literature on this subject is discussed.

Keywords

Gastrointestinal cancer chemotherapy , 5-fluorouracil , Regional arterial infusion

Gastrointestinal Sistemin Malign Hastalıklarında Kemoterapi

https://izlik.org/JA34ZF94AK

Abstract

Son senelere ait literatürün ışığı altında, sistemik ve regional kanser kemoterapisinde kullanılmakta olan ilâçlar gözden geçirildi ve bunların gastrointestinal sistemin malign hastalıklarındaki yeri ve değeri münakaşa, edildi.

Keywords

Gastrointestinal kanser kemoterapisi , 5-fluorouracil , Bölgesel arteriyel infüzyon

References

• Sherlock, P., Bhrlich, A.N., Pavon, E.E., Paglia, M.A. Treatment of gastrointestinal cancer - Current status and progress. Gastroenterology, 58: 630, 1967.
• Sullivan, R.D., Oberfield, R.A. Chemotherapy of metastatic gastrointestinal cancer. Med. Clin. of N. Amer., 50: 427, 1966.
• Shahon, D.B., Lunseth, J.B., Wagensteen, G.O.H. Gastric cancer follow-up studies at the University of Minnesota Hospital, 1950-1953. Univ. Minn. Med. Bull., 80: 366, 1959.
• Long, L., Roberts, S., McGrath, R., McGrew, E., Cole, W.H. Cancer cells in the bloodstream. Arch. Surg., 80: 639, 1960.
• Cameron, C.S. Cancer statistics - Incidence, mortality, and results of treatment. Med. Clin. of N. Amer., 40: 581, 1956.
• Tilney, N.L., Economou, S.B.G. Chemotherapy of gastrointestinal cancer. Geriatrics, 20: 265, 1965.
• Modell, W. Chemotherapy of cancer. Drug of Choice 1967, Chapter 33: 593, 1967.
• C.A.M.A. Council on Drugs Antineoplastic agents. New Drugs 1966 Edition, Chapter 46: 460, 1966.
• Hurley, J.D., Trump, D.S., Flatley, T.J., Riesce, J.D. A method of selecting patients for cancer chemotherapy. Arch. Surg., 83: 611, 1961.
• Nugujnd, T.P., Bacon, H.E. Management of inoperable carcinoma with particular reference to the use of Cytoxan - Preliminary Report. Dis. Colon and Rectum, 4: 62, 1961.
• Coggins, P.R., Raudin, R.G., Bisman, B.H. Clinical evaluation of new alkylating agent: Cytoxan (Cyclophosphamide). Cancer, 13: 1254, 1960.
• Izpapac, R., Petrakis, N.L., Amini, F., Wood, D.A. Comparative clinical evaluation of two alkylating agents. J. A.M.A., 172: 1387, 1960.
• Hurley, J.D., Ellison, E.B. Chemotherapy of solid cancer arising from the gastrointestinal tract. Ann. Surg., 152: 568, 1960.
• Economou, S.G., Mrazek, R., Cole, W.H. Adjunctive cancer chemotherapy in surgery of the colon and rectum. Dis. Colon and Rectum, 1: 44, 1958.
• Rousselot, L.M., Cole, D.R., Slattery, J., Conte, A.J. Intraluminal visceral perfusion as adjuvant chemotherapy to surgery for gastrointestinal cancer. Surgery, 52: 232, 1962.
• Hurley, J.D., Ellison, E.B., Carey, L.C. Treatment of the gastrointestinal tract with antitumor agents. Gastroenterology, 41: 557, 1961.
• Hachenthal, C.A., Golbey, R.B., Tan, C.T., Karnofsky, D.A., Burchenal, J.H. Clinical observation on the effects of streptomycin in patients with neoplastic disease. Antibiot. Chemother., 11: 178, 1960.
• Sokte, K., Takeishi, T., Nogachi, T. Clinical trials of mitomycin C (Anti-tumor substance). Chemotherapy, 6: 223, 1957.
• Kofman, S., Eisenstein, R. Mithramycin in the treatment of disseminated cancer. Cancer Chemother. Rep., 82: 77, 1963.
• Roechlin, D.B., Shiner, J., Langdom, E., Ottoman, R. Use of 5-fluorouracil in disseminated solid neoplasms. Ann. Surg., 156: 105, 1962.
• Vattkevicius, V.K., Brennan, L.L., Beckett, V.L., Kelly, J.E., Talley, R.W. Clinical evaluation of cancer chemotherapy with 5-fluorouracil. Cancer, 14: 131, 1961.
• Moertel, C.G., Rettemeyer, R.J., Hahn, R.G. Fluorinated pyrimidine therapy of advanced cancer. Gastroenterology, 46: 371, 1964.
• Olson, K.B., Grbene, J.R. Evaluation of 5-fluorouracil in the treatment of cancer. J. Nat. Cancer Inst., 28: 133, 1960.
• Hyman, G.A., Ultman, J.E., Habif, D.V. Factors to be considered in the clinical evaluation of a new chemotherapeutic agent (5-fluorouracil). Cancer Chemotherapy Rep., 16: 397, 1962.
• Ellison, R.R. Experience with fluorinated pyrimidines in adenocarcinoma of the lower intestinal tract. New York J. Med., 62: 2364, 1962.
• Heidelberger, C., Ansfield, F.J. Experimental and clinical use of fluorinated pyrimidines in cancer chemotherapy. Cancer Res., 23: 1126, 1963.
• Ellison, R.R. Clinical applications of the fluorinated pyrimidines. Med. Clin. of N. Amer., 45: 677, 1961.
• Ansfield, F.J., Schroeder, J.M., Curreri, A.R. Five years clinical experience with 5-fluorouracil. J. A.M.A., 181: 295, 1962.
• Sullivan, R.D., Young, C.W., Miller, E., Glatstein, N., Clarkson, B., Burchenal, J.H. Further clinical comparison between 5-fluorouracil (5-FU) and 5-fluoro-2-deoxyuridine (5-FUDR). Cancer Chemother. Rep., 82: 101, 1963.
• Zubrad, G.C.G. Effects of 5-fluorouracil and fluorodeoxyuridine on gastro-intestinal cancer. J. A.M.A., 178: 832, 1961.
• Young, C.W., Ellison, R.R., Sullivan, R.D., Levick, S.N., Kaufman, R., Miller, E., Weldow, I., Escher, G., Li, M.C., Karnofsey, D.A., Burchenal, J.H. Clinical evaluation of 6-fluorouracil and 5-fluoro-2-deoxyuridine in solid tumors in adults - A progress report. Cancer Chemother. Rep., 6: 17, 1960.
• Sullivan, R.D., Young, C.W., Miller, E., Glatstein, N., Clarkson, B., Burchenal, J.H. Clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2-deoxyuridine). Cancer Chemother. Rep., 8: 97, 1960.
• Allaire, F.J., Thieme, E.T., Kurst, D.R. Cancer chemotherapy with 5-fluorouracil alone and combination with x-ray therapy. Cancer Chemother. Rep., 14: 59, 1961.
• Von Essen, C.F., Kligerman, M.M., Calabresi, P. Radiation and 5-fluorouracil - A controlled clinical study. Radiology, 81: 843, 1963.
• Hodnett, E.M. Drugs used with radiation in the treatment of cancer. Cancer Chemother. Rep., 32: 55, 1968.
• Langdom, E.A., Ottoman, R.E., Rochlin, D.B., Snart, C.R. Early results of combined radiation and chemotherapy in treatment of malignant tumors. Radiology, 81: 1008, 1963.
• Ansfield, F.J., Schroeder, J.M., Curreri, A.R. A preliminary comparison of 5-fluoro-2-deoxyuridine administered by rapid daily intravenous injections and slow continuous infusion. Cancer Chemother. Rep., 16: 389, 1962.
• Schoenbaceh, E.B., Colsky, J., Greenspan, E.M. Observations on effects of folic acid antagonists, aminopterin and amethopterin, in patients with advanced neoplasmaf. Cancer, 5: 1201, 1952.
• Sullivan, R.D., Miller, E., Sykes, M.P. Antimetabolite-metabolite combination cancer chemotherapy. Effects of intra-arterial methotrexate-intramuscular citrovorum factor therapy in human cancer. 12: 1248, 1959.
• Shingleton, W.W., Reeves Jr., Keppel, R.A., Mahaley, S., Taylor, H.M. Studies on abdominal organ perfusion for cancer chemotherapy. Ann. Surg., 151: 741, 1960.
• Martin, D.S., White, H.M. Jr. Control of leaking pelvic perfusion. Cancer Chemother. Rep., 16: 553, 1962.
• Lawrence, W. Jr., Clarkson, B., Kim, M., Clapp, P., Randall, H.T. Regional perfusion of pelvis and abdomen by an indirect technique. Cancer, 16: 567, 1963.
• Rochlin, D.B., Smart, C.R., Shiner, J. The control of systemic admixture during isolation perfusion. Surg. Gynec. Obstet., 116: 11, 1963.
• Lawrance, W. Jr., Kulkin, P., Masle, E.T., Miller, D.G. An abdominal tourniquet for regional chemotherapy. J. Surg. Res., 1: 142, 1961.
• Ryan, R.E., Schramel, R.C., Creech, O. Jr. Value of perfusion in pelvic surgery. Dis. Colon Rectum, 8: 291, 1963.
• Young, L.J., Hurley, J.D. Pelvic perfusion for carcinoma of the colon. Amer. J. Surg., 105: 102, 1968.
• Nora, P.F., Apostol, J.W. Arterial infusion chemotherapy for locally advanced cancer. Surg. Clin. of North Amer., 47: 195, 1967.
• Helsper, J.T., De Moss, E.V. Regional intra-arterial infusion of 5-fluorouracil for cancer. Surgery, 56: 340, 1964.
• Johnson, R.O., Kisken, W.A., Curreri, A.R. A report upon arterial infusion with 5-fluorouracil in 100 patients. Surg. Gynec. Obstet., 120: 530, 1965.
• Bayly, J.H., Carbalhaes, O.G. The umbilical vein in the adult - Diagnosis, treatment and research. Amer. Surgeon, 30: 56, 1964.
• Storer, E.H., Akin, T.J. Chemotherapy of hepatic neoplasms via the umbilical - portal vein. Amer. J. Surg., 111: 56, 1966.
• Sherlock, P. Acute gastritis resulting from regional infusion of an antimetabolite. Bull. Gastroint. Endosc., 9: 16, 1963.
• Sullivan, R.D., Zureck, W.Z. Chemotherapy for liver cancer by protracted ambulatory infusion. J. A.M.A., 194: 481, 1965.
• Khazfi, A.M., Watkins, E. Jr., Sullivan, R.D. Hepatic artery catheterization for prolonged infusion chemotherapy of liver cancer. Surg. Clin. of N. Amer., 44: 763, 1964.
• Watkins, E. Jr. Chemometric infusion - An apparatus for protracted ambulatory infusion therapy. New Engl. J. Med., 269: 850, 1963.
• Sullivan, R.D., Norcross, J.M., Watkins, E. Jr. Chemotherapy of metastatic liver cancer by prolonged hepatic artery infusion. New Engl. J. Med., 270: 301, 1964.
• Rochlin, D.B., Smart, C.R. An evaluation of 51 patients with hepatic artery infusion. Surg. Gynec. Obstet., 128: 535, 1966.
• Wagner, D.E., Baum, B. Preliminary arteriography in hepatic artery infusions for cancer. Surg. Gynec. Obstet., 120: 817, 1965.
• Clarkson, B., Young, G.C., Dierick, W., Kuehn, P., Kim, M., Berrett, A., Clapp, P., Lawrence, W. Effects of continuous hepatic artery infusion of antimetabolites. Cancer, 15: 472, 1962.
• Watkins, E. Jr., Sullivan, R.D. Cancer chemotherapy by prolonged arterial infusion. Surg. Gynec. Obstet., 118: 3, 1964.
• Byron, R.L. Jr., Percey, F.M., Yonemoto, R.H., Bierman, R.H., Gildenhorn, H.L., Kelly, K.H. Left brachial arterial catheterization for chemotherapy in advanced intraabdominal neoplasms. Surg. Gynec. Obstet., 112: 689, 1961.
• Grossi, C.E., Rousselot, L.M., Gonzaless, H.E.M., Conte, A.J. Selective concentration in liver and thoracic duct lymph of anticancer drugs by hepatic outflow block. Amer. J. Surg., 111: 59, 1965.
• Rousselot, L.M., Grossl, G.C.E., Slattery, J., Rossi, P., Conte, A.J., Ruzicka, F.P. Jr. Hepatic outflow occlusion during hepatic artery infusion with chemotherapeutic agents. Cancer, 17: 1579, 1964.
• Johnson, H.A., Rubini, J.R., Cronkite, E.P., Bond, U.P. Labelling of human tumor cells in vivo by tritiated thymidine. Lab. Invest., 9: 460, 1960.
• Cole, W.H. Chemotherapy of colon tumors. Amer. J. Surg., 103: 94, 1962.
• Soutwick, H.W., Harridge, W.H., Cole, W.H. Recurrence at the suture line following resection for carcinoma of colon. Amer. J. Surg., 103: 86, 1962.
• Cole, W.H., Economou, B.G., Hunter, J. Carcinoma of the colon and rectum. Surg. Clin. of N. Amer., 42: 519, 1962.
• Johnson, I.B., Armstrong, J.G., Gorman, M., Burnett, B. Jr. The vinca alkaloid: A new class of oncolytic agents. Cancer Res., 23: 1390, 1963.
• Mengel, C.E., Weaver, W., Holloway, L., Anlyan, W.G. Adjuvant therapy of malignant carcinoid syndrome. Surgery, 54: 182, 1963.
• Reed, M.L., Kuipers, F.M., Vattkevicius, V.K., Clare, M.D., Drake, E.H., Eyler, W.R. Treatment of disseminated carcinoid tumors including hepatic artery catheterization. New Engl. J. Med., 269: 1005, 1963.
• Zimmer, P.F. E. Islet-cell carcinoma treated with alloxan. Ann. Int. Med., 61: 543, 1964.
• Brown, H., Hargreaves, H.P., Tyler, P.P.H. Islet-cell adenoma of pancreas; metabolic studies on patient treated with corticotropin and cortisone. Arch. Intern. Med., 89: 951, 1952.
• Landau, B.R., Levine, H.J., Hertz, R. Prolonged glucagon administration in a case of hyperinsulinism due to disseminated islet-cell carcinoma. New Engl. J. Med., 258: 286, 1958.
• Roth, H., Thjer, S., Segal, B. Zinc glucagon in the management of refractory hypoglycemia due to insulin-producing tumors. New Engl. J. Med., 274: 493, 1966.
• Ernest, M., Mitchell, M.L., Raben, M.S., Gilboa, Y. Control of hypoglycemia with diazoxide and human growth hormone. Lancet, 1: 628, 1965.
• Bleicher, B.I., Chowdhury, F., Goldner, M.G. Thiazide therapy in hypoglycemia of metastatic insulinoma. Clin. Res., 12: